References
- Malamatari M, Taylor KMG, Malamataris S, et al. Pharmaceutical nanocrystals: production by wet milling and applications. Drug Discov Today. 2018 March 01;23(3):534–547.
- Merisko-Liversidge E, Liversidge GG, Cooper ER. Nanosizing: a formulation approach for poorly-water-soluble compounds. Eur J Pharm Sci. 2003 Feb 01;18(2):113–120.
- Krause KP, Kayser O, Mäder K, et al. Heavy metal contamination of nanosuspensions produced by high-pressure homogenisation. Int J Pharm. 2000;196(2):169–172.
- Sun CC, Kiang YH. On the identification of slip planes in organic crystals based on attachment energy calculation. J Pharm Sci. 2008 Aug 01;97(8):3456–3461.
- Agrawal S, Ashokraj Y, Bharatam PV, et al. Solid-state characterization of rifampicin samples and its biopharmaceutic relevance. Eur J Pharm Sci. 2004 Jun 01;22(2):127–144.
- Heng JYY, Bismarck A, Lee AF, et al. Anisotropic surface chemistry of aspirin crystals. J Pharm Sci. 2007 Aug 01;96(8):2134–2144.
- Singhal D, Curatolo W. Drug polymorphism and dosage form design: a practical perspective. Adv Drug Del Rev. 2004 Feb 23;56(3):335–347.
- Tiwary AK. Modification of crystal habit and its role in dosage form performance. Drug Dev Ind Pharm. 2001 Jan 01; 27(7):699–709.
- Mishra MK, Desiraju GR, Ramamurty U, et al. Studying microstructure in molecular crystals with nanoindentation: intergrowth polymorphism in felodipine. Angew Chem Int Ed. 2014;53(48):13102–13105.
- Lindfors L, Forssen S, Westergren J, et al. Nucleation and crystal growth in supersaturated solutions of a model drug. J Colloid Interface Sci. 2008 Sep 15;325(2):404–413.
- Di Martino P, Beccerica M, Joiris E, et al. Influence of crystal habit on the compression and densification mechanism of ibuprofen. J Cryst Growth. 2002 Aug;243(2):345–355.
- Hu J, Johnston KP, Williams RO. Nanoparticle engineering processes for enhancing the dissolution rates of poorly water soluble drugs. Drug Dev Ind Pharm. 2004 Jan 01;30(3):233–245.
- Chow AHL, Tong HHY, Chattopadhyay P, et al. Particle Engineering for Pulmonary Drug Delivery [journal article]. Pharm Res. 2007 March 01;24(3):411–437.
- Modi SR, Dantuluri AKR, Puri V, et al. Impact of crystal habit on biopharmaceutical performance of celecoxib. Cryst Growth Des. 2013;13(7):2824–2832.
- Medroxyprogesterone Acetate. The American Society of health-system pharmacists archived from the original on 24 December 2016. 2016 December 8.
- Glasier A. Contraception. In: DeGroot LJ, Jameson JL, editors. Endocrinology. 5th ed. Philadelphia: Elsevier Saunders; 2006. p. 2993–3003. ISBN 978-0-7216-0376-6.
- Kuhl H. Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric. 2005;8(sup1):3–63.
- Depo-Provera® Contraceptive Injection Physician Information.
- Puri V, Bansal AK. In vitro-in vivo characterization of release modifying agents for parenteral sustained-release ketorolac formulation. Drug Dev Ind Pharm. 2004;30(6):619–626.
- Hardinger AS. A simple demonstration of the effect of impurities on melting point. J Chem Educ. 1995;72(3):472–483.
- Sovizi MR, Hajimirsadeghi SS, Naderizadeh B. Effect of particle size on thermal decomposition of nitrocellulose. J Hazard Mater. 2009;168(2–3):1134.
- Guo Z, Jones AG, Li N. Interpretation of the ultrasonic effect on induction time during BaSO 4 homogeneous nucleation by a cluster coagulation model. J Colloid Interface Sci. 2012;297(1):190–198.
- Chow R, Blindt R, Chivers R, et al. A study on the primary and secondary nucleation of ice by power ultrasound. Ultrasonics. 2005 Feb 01;43(4):227–230.
- Amara N, Ratsimba B, Wilhelm A-M, et al. Crystallization of potash alum: effect of power ultrasound. Ultrason Sonochem. 2001 Jul 01;8(3):265–270.
- Kim D-C, Yeo S-D. Habit modification of tamoxifen crystals using antisolvent crystallizations [journal article]. Korean J Chem Eng. 2017 May 01;34(5):1466–1474.
- Stoica C, Verwer P, Meekes H, et al. Understanding the effect of a solvent on the crystal habit. Cryst Growth Des. 2004;4(4):765–768.
- Morphological Control ZY. Study on the crystallization process of organic compounds. Nanjing: Tianjin University; 2005 [in Chinese].
- Medlicott NJ, Waldron NA, Foster TP. Sustained release veterinary parenteral products. Adv Drug Del Rev. 2004 Jun 23;56(10):1345–1365.
- Anderson FD, Archer DF, Harman SM, et al. Tissue response to bioerodible, subcutaneous drug implants: a possible determinant of drug absorption kinetics [journal article]. Pharm Res. 1993 March 01;10(3):369–380.
- Sahay G, Alakhova DY, Kabanov AV. Endocytosis of nanomedicines. J Control Release. 2010;145(3):182–195.
- Champion JA, Katare YK, Mitragotri S. Making polymeric micro- and nanoparticles of complex shapes [Article]. Proc Natl Acad Sci U S A. 2007;104(29):11901–11904.
- Champion JA, Mitragotri S. Role of target geometry in phagocytosis [Article]. Proc Natl Acad Sci U S A. 2006;103(13):4930–4934.